Innventure, Inc. (NASDAQ: INV) Securities Investigation: Investors Who Held Shares Since November 17, 2025, May Be Eligible to Seek Compensation – Stranch, Jennings & Garvey, PLLC

  • Post author:
  • Post category:Business

OAKLAND, Calif., Oct. 21, 2026 /PRNewswire/ -- Stranch, Jennings & Garvey, PLLC is investigating potential securities law violations involving Innventure, Inc. (NASDAQ: INV) and allegations concerning the company's disclosures about a data center agreement between its subsidiary, Accelsius, and…

Continue ReadingInnventure, Inc. (NASDAQ: INV) Securities Investigation: Investors Who Held Shares Since November 17, 2025, May Be Eligible to Seek Compensation – Stranch, Jennings & Garvey, PLLC

Suburban Propane Partners, L.P. to Hold Fiscal 2026 Full Year and Fourth Quarter Results Conference Call

  • Post author:
  • Post category:Business

WHIPPANY, N.J., Oct. 21, 2026 /PRNewswire/ -- Suburban Propane Partners, L.P. (NYSE: SPH), announced today that it has scheduled its Fiscal 2026 Full Year and Fourth Quarter Results Conference Call for Thursday, November 12, 2026 at 9:00 AM…

Continue ReadingSuburban Propane Partners, L.P. to Hold Fiscal 2026 Full Year and Fourth Quarter Results Conference Call

S4 Capital’s Monks Accelerates Regional Growth Strategy in EMEA and APAC Expanding Nirvik Singh’s Remit to APAC, Names Ash Smith Executive Vice President, Asia Pacific and Fay Denis du Peage Managing Director, Australia and New Zealand

  • Post author:
  • Post category:Business

LONDON, Oct. 21, 2026 /PRNewswire/ -- Monks, the purely digital, unitary operating brand of S4 Capital plc, today announced an evolution of its regional leadership across EMEA and Asia-Pacific. As global brands demand more agile, connected and AI-enabled…

Continue ReadingS4 Capital’s Monks Accelerates Regional Growth Strategy in EMEA and APAC Expanding Nirvik Singh’s Remit to APAC, Names Ash Smith Executive Vice President, Asia Pacific and Fay Denis du Peage Managing Director, Australia and New Zealand

Global Times: China’s financial regulators roll out targeted policies at key financial forum, reaffirm opening-up

  • Post author:
  • Post category:Business

BEIJING, Oct. 21, 2026 /PRNewswire/ -- The Annual Conference of Financial Street Forum (FSF) 2026 kicked off in Beijing on Monday, convening a heavyweight roster of top financial regulators who rolled out targeted policies, including a pilot initiative…

Continue ReadingGlobal Times: China’s financial regulators roll out targeted policies at key financial forum, reaffirm opening-up

FF EAI Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and Nasdaq Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq’s MarketSite in NYC

  • Post author:
  • Post category:Business

FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) will hold its official listing ceremony to mark the Company's name and ticker change, and first Investor Day at the Nasdaq Tower on Monday, Oct. 26.  Subject to completion of the…

Continue ReadingFF EAI Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and Nasdaq Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq’s MarketSite in NYC

Baidu, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BIDU

  • Post author:
  • Post category:Business

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Baidu, Inc. ("Baidu" or "the Company") (NASDAQ: BIDU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934…

Continue ReadingBaidu, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BIDU

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  • Post author:
  • Post category:Business

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on October 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as…

Continue ReadingAtrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)